Suppr超能文献

冬凌草甲素药理活性的研究进展与未来发展潜力

Research Progress and Future Development Potential of Oridonin in Pharmacological Activities.

作者信息

Ye Shiying, Sun Shaowei, Cai Jiye, Jiang Jinhuan

机构信息

Institute of Pharmacy and Pharmacology, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

出版信息

Curr Mol Pharmacol. 2023;16(7):691-706. doi: 10.2174/1874467216666221130163634.

Abstract

In recent years, attention has increasingly focused on herbal medicines and their bioactive components attributed to their multi-target pharmacological activity and low side effects. Oridonin is a natural diterpenoid extracted from the traditional Chinese herb and is one of the main active components of Rabdosia rubescens. Modern pharmacological studies have shown that oridonin has anti-tumor, anti-bacterial, anti-inflammatory, anti-oxidant, cardiovascular protective, immunomodulatory, and other effects. Based on the published literature in recent years, we outline the pharmacological activities of oridonin, aiming to provide a theoretical basis for the design and development of new oridonin-based drugs, as well as to facilitate the process of oridonin for clinical use.

摘要

近年来,由于草药及其生物活性成分具有多靶点药理活性和低副作用,人们对其关注度日益增加。冬凌草甲素是从传统中药中提取的一种天然二萜类化合物,是冬凌草的主要活性成分之一。现代药理学研究表明,冬凌草甲素具有抗肿瘤、抗菌、抗炎、抗氧化、心血管保护、免疫调节等作用。基于近年来发表的文献,我们概述了冬凌草甲素的药理活性,旨在为新型冬凌草甲素类药物的设计和开发提供理论依据,并促进冬凌草甲素用于临床的进程。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验